We are delighted to introduce Richard Otto to our illustrious team of Senior Client Advisors.

“Richard was the first advisor to join BiotechExec, and has truly helped to shape our business. With a leadership track record that has led to multiple successful exits, Richard is perfectly suited to guide our clients along their commercialization pathway,” said Russell Allen, CEO of BiotechExec. Richard is a multi-faceted life science executive with decades of CEO experience in startups through publicly traded medical innovation companies.

With a leadership background in cardiovascular, gene therapy, cryotherapy, health IT and turnarounds, he brings a proven track record of commercialization to our network and the advisory group.

Read More – https://biotechexec.com/richard-otto/

“BiotechExec is a unique service for the life science community filling a vital need for specific talents and experience on an as needed basis. BiotechExec has attracted an experienced team with the background and success to match unique management needs with a senior level executive experienced in all aspects of medical device or therapeutic development,” said Otto.

Together with his fellow Senior Executive Advisory Team (SEAT) members, Richard will work with Biotech Exec’s clients to define the scope of work that will bring the greatest benefit to their organization. Our Senior Advisors will engage the members of our global network best equipped to deliver this scope and build commercial success to life science companies – to benefit their shareholders and customers, for the future of global healthcare.

Watch this space over the coming weeks as we introduce more BiotechExec Senior Client Advisors bringing unparalleled expertise to our clients and the wider business community.